scorecardresearch
Add as a preferred source on Google
Thursday, January 15, 2026
TopicVaccine

Topic: Vaccine

Stricter vaccine approval process is the last thing the US needs

ThePrint view on the most important issues.

Flagging bird flu’s ‘pandemic potential’, ICMR calls on private firms to collaborate on human vaccine

India's apex health research body has warned that H5N1 infection in humans has a high case fatality rate, exceeding 50 percent.

India’s Vaccine Regulation System Meets WHO Standards

A review was carried out by international experts between 16 and 20 September.

ICMR back in race to offer world’s 1st vaccine for deadly shigella, to tie up with Indian manufacturer

ICMR had in 2019 licensed technology for scaling up and commercialisation of its shigella vaccine to MSD-Wellcome Trust Hilleman Laboratories, but the deal fell through.

BRICS Vaccine Research Center launched in India

New Delhi: In a statement issued after the meeting, Union Health Secretary Apurva Chandra said that the BRICS Vaccine Research and Development Centre, established...

Government signs MoU with UNDP for capacity building and digitalization of vaccine cold chain management

This partnership aims to enhance the digitalization of vaccine cold chain management, capacity building, and communication planning in India.

Panel will keep watch for violation of new drug marketing code, says pharma secretary

Implemented in March, UCPMP 2024 will look into complaints regarding unethical practices in sector. Code gains significance given that Patanjali is facing SC heat for misleading ads.

Global panel calls for scaling up cholera vaccine supply to combat ongoing upsurge in cases

International Coordinating Group (ICG) on Vaccine Provision (ICG) noted that 473,000 cases of cholera were reported to the WHO in 2022.

Govt for the first time considers pre-exposure anti-rabies shots for kids as dog bite cases ‘rise’

National Centre for Disease Control formed panel to discuss such vaccinations through Universal Immunization Programme. Evidence being gathered to present to NTAGI, it is learnt.

World’s 1st vaccine against chikungunya primed for launch in India, says French drugmaker Valneva

VLA1553, commercially known as Ixchiq, has received USFDA clearance and will be launched in India — which has seen high number of chikungunya cases — after ‘regulatory talks with DCGI’.

On Camera

India’s nuclear-power goal needs more than capital

New Delhi has finally accepted that the base load power demand of the future will need supplementing, and nuclear plants are one way to go about it.

Coastal states Maharashtra, TN, Gujarat top India’s exports index, landlocked UP a surprise performer

Releasing Export Preparedness Index report, NITI Aayog CEO says Centre has ‘ticked a lot of boxes’, & responsibility of driving the next phase of export growth now rests with states.

Rafale deal to be inked in 2026, final assembly line in Nagpur, Indian firms to be roped in

The proposed project costing about Rs 3.25 lakh crore will entail procurement of 18 aircraft in fly away condition & the rest made in India with up to 60% indigenous content.

Thank you Donald Trump, again. India now has reason to shed fear of trade deals and risky reform

UK, EFTA already in the bag and EU on the way, many members of RCEP except China signed up, and even restrictions on China being lifted, India has changed its mind on trade.